XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 07.02.2025

The following instruments on Boerse Frankfurt do have their last trading day on 07.02.2025
Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 07.02.2025

ISIN Name
CA09226M1005 BLACK SWAN GRAPHENE INC.
CA17040T3001 CHORUS AVIAT.(VOT.+VAR.)
CA78573W2013 SABRE GOLD MINES CORP.
DE000CB0HR43 COBA MTH S.P45
IT0001350625 OLIDATA
US05875B1061 BALLYS CORP. DL-,01
US09075P1057 BIOXCEL THERAPEUT DL-,001
US33817P3064 FITLIFE BRANDS NEW DL-,01
US6983412031 PANDORA SP.ADR 1/4 DK 1
US7613301099 REVANCE THERAPEUT.DL-,001
US87807D5095 TC BIOPHA.(H.)SP. ADS/200
XS1760383577 GREENLAND GL.INV. 18/29

Zeit	Aktuelle Nachrichten
Do	Bally's buyout last chance for AU firm as H1 confirms tough times
Do	XFRA NEW INSTRUMENTS AVAILABLE ON 17.04.2025	The following instruments on XETRA do have their first trading 17.04.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 17.04.2025 Aktien 1 AU0000082422 Harvest Technology Group... ► Artikel lesen
Mi	Star's long-delayed 1H25 report shows AU$302 million loss but Bally's deal offers new hope
Di	Bally's Mulled Waiting for Star to Fall Into Administration
Mo	Bally's swooped for Star after Australian casino group's fire sale, chairman says

Zeit

Aktuelle Nachrichten

Bally's buyout last chance for AU firm as H1 confirms tough times

XFRA NEW INSTRUMENTS AVAILABLE ON 17.04.2025

The following instruments on XETRA do have their first trading 17.04.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 17.04.2025 Aktien 1 AU0000082422 Harvest Technology Group...
► Artikel lesen

Star's long-delayed 1H25 report shows AU$302 million loss but Bally's deal offers new hope

Bally's Mulled Waiting for Star to Fall Into Administration

Bally's swooped for Star after Australian casino group's fire sale, chairman says

Zeit	Aktuelle Nachrichten
04.04.	BioXcel Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans
03.04.	BioXcel Therapeutics, Inc. - 8-K, Current Report
29.03.	BioXcel Therapeutics zeigt Fortschritte trotz Verlusten
28.03.	BioXcel Therapeutics, Inc. - 10-K, Annual Report
27.03.	BioXcel Therapeutics, Inc. Q4 Loss Declines

Zeit

Aktuelle Nachrichten

04.04.

BioXcel Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans

03.04.

BioXcel Therapeutics, Inc. - 8-K, Current Report

29.03.

BioXcel Therapeutics zeigt Fortschritte trotz Verlusten

28.03.

BioXcel Therapeutics, Inc. - 10-K, Annual Report

27.03.

BioXcel Therapeutics, Inc. Q4 Loss Declines

Zeit	Aktuelle Nachrichten
25.02.	Black Swan Graphene Inc (2): Black Swan appoints Roadcap as head of technical sales
25.02.	Black Swan Graphene Inc.: Black Swan Graphene Announces the Appointment of Industry Veteran Dan Roadcap as Head of Technical Sales and Business Development	Toronto, Ontario--(Newsfile Corp. - February 25, 2025) - Black Swan Graphene Inc. (TSXV: SWAN) (OTCQB: BSWGF) (FSE: R960) ("Black Swan" or the "Company") is pleased to announce the strategic appointment... ► Artikel lesen
21.02.	Black Swan Graphene Inc (2): Black Swan hires Capital Analytica for IR services
21.02.	Black Swan Graphene Inc.: Black Swan Graphene Retains Public Awareness Consultant and Announces Grant of Stock Options and Restricted Share Units	Toronto, Ontario--(Newsfile Corp. - February 21, 2025) - Black Swan Graphene Inc. (TSXV: SWAN) (OTCQB: BSWGF) (FSE: R96) ("Black Swan" or the "Company") is pleased to announce it has entered into an... ► Artikel lesen
12.02.	Black Swan Graphene Inc (2): Black Swan Graphene closes $6-million private placement

Zeit

Aktuelle Nachrichten

25.02.

Black Swan Graphene Inc (2): Black Swan appoints Roadcap as head of technical sales

25.02.

Black Swan Graphene Inc.: Black Swan Graphene Announces the Appointment of Industry Veteran Dan Roadcap as Head of Technical Sales and Business Development

Toronto, Ontario--(Newsfile Corp. - February 25, 2025) - Black Swan Graphene Inc. (TSXV: SWAN) (OTCQB: BSWGF) (FSE: R960) ("Black Swan" or the "Company") is pleased to announce the strategic appointment...
► Artikel lesen

21.02.

Black Swan Graphene Inc (2): Black Swan hires Capital Analytica for IR services

21.02.

Black Swan Graphene Inc.: Black Swan Graphene Retains Public Awareness Consultant and Announces Grant of Stock Options and Restricted Share Units

Toronto, Ontario--(Newsfile Corp. - February 21, 2025) - Black Swan Graphene Inc. (TSXV: SWAN) (OTCQB: BSWGF) (FSE: R96) ("Black Swan" or the "Company") is pleased to announce it has entered into an...
► Artikel lesen

12.02.

Black Swan Graphene Inc (2): Black Swan Graphene closes $6-million private placement

Zeit	Aktuelle Nachrichten
Di	Chorus Aviation Inc (2): Chorus arranges SIB to buy back up to $25M of shares
Mo	Chorus Aviation Announces Commencement of Substantial Issuer Bid
07.04.	Chorus Aviation Inc (2): Chorus Aviation to release Q1 2025 results May 7
07.04.	Chorus Aviation Inc (2): Chorus Aviation arranges substantial issuer bid
07.04.	Stocks in Play: Chorus Aviation Inc.

Zeit

Aktuelle Nachrichten

Chorus Aviation Inc (2): Chorus arranges SIB to buy back up to $25M of shares

Chorus Aviation Announces Commencement of Substantial Issuer Bid

07.04.

Chorus Aviation Inc (2): Chorus Aviation to release Q1 2025 results May 7

07.04.

Chorus Aviation Inc (2): Chorus Aviation arranges substantial issuer bid

07.04.

Stocks in Play: Chorus Aviation Inc.

Zeit	Aktuelle Nachrichten
29.03.	FitLife Brands zeigt starkes Wachstum im letzten Quartal
27.03.	FitLife Brands GAAP EPS of $0.21, revenue of $15.01M beats by $0.06M
27.03.	FITLIFE BRANDS, INC. - 8-K, Current Report
27.03.	FITLIFE BRANDS, INC. Reveals Increase In Q4 Profit
27.03.	FITLIFE BRANDS, INC. - 10-K, Annual Report

Zeit

Aktuelle Nachrichten

29.03.

FitLife Brands zeigt starkes Wachstum im letzten Quartal

27.03.

FitLife Brands GAAP EPS of $0.21, revenue of $15.01M beats by $0.06M

27.03.

FITLIFE BRANDS, INC. - 8-K, Current Report

27.03.

FITLIFE BRANDS, INC. Reveals Increase In Q4 Profit

27.03.

FITLIFE BRANDS, INC. - 10-K, Annual Report

Zeit	Aktuelle Nachrichten
10.02.	XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 10.02.2025	The following instruments on XETRA do have their first trading 10.02.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 10.02.2025 Aktien 1 SE0023615638 Asmodee Group AB 2... ► Artikel lesen
07.02.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 07.02.2025	The following instruments on Boerse Frankfurt do have their last trading day on 07.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 07.02.2025ISIN NameCA09226M1005 BLACK... ► Artikel lesen
07.02.	XFRA ISIN CHANGE	Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA09226M1005 Black Swan Graphene Inc. 07.02.2025 CA09226M2094 Black Swan Graphene Inc. 10.02.2025 Tausch 8:1CA17040T3001 Chorus... ► Artikel lesen
07.02.	XFRA CAPITAL ADJUSTMENT INFORMATION - 07.02.2025	Das Instrument PQ51 CA6993202069 PARAMOUNT RES LTD CLASS A EQUITY wird cum Kapitalmassnahme gehandelt am 07.02.2025 und ex Kapitalmassnahme am 10.02.2025 The instrument PQ51 CA6993202069 PARAMOUNT RES... ► Artikel lesen

Zeit

Aktuelle Nachrichten

10.02.

XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 10.02.2025

The following instruments on XETRA do have their first trading 10.02.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 10.02.2025 Aktien 1 SE0023615638 Asmodee Group AB 2...
► Artikel lesen

07.02.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 07.02.2025

07.02.

XFRA ISIN CHANGE

Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA09226M1005 Black Swan Graphene Inc. 07.02.2025 CA09226M2094 Black Swan Graphene Inc. 10.02.2025 Tausch 8:1CA17040T3001 Chorus...
► Artikel lesen

07.02.

XFRA CAPITAL ADJUSTMENT INFORMATION - 07.02.2025

Das Instrument PQ51 CA6993202069 PARAMOUNT RES LTD CLASS A EQUITY wird cum Kapitalmassnahme gehandelt am 07.02.2025 und ex Kapitalmassnahme am 10.02.2025 The instrument PQ51 CA6993202069 PARAMOUNT RES...
► Artikel lesen

Zeit	Aktuelle Nachrichten
18.02.	Revance Therapeutics, Inc. - 15-12G, Securities registration termination
07.02.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 07.02.2025	The following instruments on Boerse Frankfurt do have their last trading day on 07.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 07.02.2025ISIN NameCA09226M1005 BLACK... ► Artikel lesen
06.02.	Crown Labs schließt Übernahme von Revance Therapeutics ab
06.02.	Crown Laboratories, Inc.: Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics	The business combination reinforces Crown's position as a leading, innovative, high-growth aesthetics and skincare company JOHNSON CITY, Tenn., Feb. 6, 2025... ► Artikel lesen
06.02.	NSE - Revance Therapeutics, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities

Zeit

Aktuelle Nachrichten

18.02.

Revance Therapeutics, Inc. - 15-12G, Securities registration termination

07.02.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 07.02.2025

06.02.

Crown Labs schließt Übernahme von Revance Therapeutics ab

06.02.

Crown Laboratories, Inc.: Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics

The business combination reinforces Crown's position as a leading, innovative, high-growth aesthetics and skincare company JOHNSON CITY, Tenn., Feb. 6, 2025...
► Artikel lesen

06.02.

NSE - Revance Therapeutics, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities

Zeit	Aktuelle Nachrichten
21.03.	Why TC Biopharm (TCBP) Stock Is Down Over 60% Today
21.03.	TC BioPharm To Be Delisted From Nasdaq, Plans Transition To OTC Markets
21.03.	TC BioPharm: TCBP Announces Transition from Nasdaq to OTC Markets	EDINBURGH, Scotland, March 21, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company"), (NASDAQ: TCBP) a clinical-stage biotechnology... ► Artikel lesen
21.03.	TC BioPharm plc - 6-K, Report of foreign issuer
21.03.	TC BioPharm to be delisted from Nasdaq, moves to OTC Markets

Zeit

Aktuelle Nachrichten

21.03.

Why TC Biopharm (TCBP) Stock Is Down Over 60% Today

21.03.

TC BioPharm To Be Delisted From Nasdaq, Plans Transition To OTC Markets

21.03.

TC BioPharm: TCBP Announces Transition from Nasdaq to OTC Markets

EDINBURGH, Scotland, March 21, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company"), (NASDAQ: TCBP) a clinical-stage biotechnology...
► Artikel lesen

21.03.

TC BioPharm plc - 6-K, Report of foreign issuer

21.03.

TC BioPharm to be delisted from Nasdaq, moves to OTC Markets

Unternehmen / Aktien	Kurs	%
BALLYS CORPORATION	13,862	0,00 %
BIOXCEL THERAPEUTICS INC	1,365	-100,00 %
BLACK SWAN GRAPHENE INC	0,470	0,00 %
CHORUS AVIATION INC	11,700	+0,86 %
FITLIFE BRANDS INC	5,800	+11,54 %
OLIDATA SPA	1,864	-0,75 %
REVANCE THERAPEUTICS INC	3,420	0,00 %
TC BIOPHARM HOLDINGS PLC ADR	0,825	0,00 %

Unternehmen / Aktien

Kurs

BALLYS CORPORATION

13,862

0,00 %

BIOXCEL THERAPEUTICS INC

1,365

-100,00 %

BLACK SWAN GRAPHENE INC

0,470

0,00 %

CHORUS AVIATION INC